Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

26 Nov 2021 13:00

RNS Number : 7435T
Chesnara PLC
26 November 2021
 

CHESNARA plc

("Chesnara" or "the Company")

 

26 November 2021

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ('PDMRs')

 

Further to the appointment of Steve Murray as Group Chief Executive on 19 October 2021, Chesnara plc (the 'Company') today announces that, under the terms of his appointment, Steve (a PDMR) was granted awards in the ordinary shares of the Company under the Chesnara plc 2014 Long-Term Incentive Scheme to compensate him for remuneration arrangements forfeited on leaving his former employer, The Royal London Mutual Insurance Society Limited. These awards were made in accordance with the Company's Directors' Remuneration Policy and are subject to the Executive Directors' Minimum Shareholding Policy.

 

The notification below, which is being made in accordance with the requirements of Article-19 of the EU Market Abuse Regulation 596/2014 as retained in UK law by virtue of the European Union (Withdrawal) Act 2018, provides further detail of the awards granted.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

Steven Grant Murray

2

Reason for the notification

a)

Position/status:

Executive Director and Group Chief Executive

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target ending 31 December 2021.

 

Subject to the achievement of the performance target, the option will become exercisable on 31 December 2021 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target ending 31 December 2021.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 June 2022 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 3

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target ending 31 December 2022.

 

Subject to the achievement of the performance target, the option will become exercisable on 31 December 2022 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

GRANT 4

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 31 December 2022.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 April 2023 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 5

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 30 June 2023.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 June 2023 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 6

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 31 December 2023.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 April 2024 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

GRANT 7

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to performance targets ending 31 December 2023.

 

Subject to the achievement of the performance target, the option will become exercisable on 30 June 2024 and remain exercisable up to and including 26 November 2031 if not exercised before that date.

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

50,456 Ordinary shares of 5p each

Nil

GRANT 2

119,089 Ordinary shares of 5p each

Nil

GRANT 3

50,456 Ordinary shares of 5p each

Nil

GRANT 4

119,089 Ordinary shares of 5p each

Nil

GRANT 5

20,722 Ordinary shares of 5p each

Nil

GRANT 6

140,105 Ordinary shares of 5p each

Nil

GRANT 7

33,625 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 533,542 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2021-11-26

f)

Place of the transaction

XOFF

 

 

Name of authorised official of issuer responsible for making notification: - Al Lonie

 

Date of notification: - 26 November 2021

 

For further information, please contact:

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers approximately 900,000 policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGBPGUPGGUQ
Date   Source Headline
22nd Oct 20195:11 pmRNSHolding(s) in Company
2nd Oct 20195:11 pmRNSHolding(s) in Company
30th Sep 20195:00 pmRNSTotal Voting Rights
30th Sep 20192:33 pmRNSHolding(s) in Company
20th Sep 20199:00 amRNSHolding(s) in Company
19th Sep 20195:00 pmRNSHolding(s) in Company
12th Sep 20195:24 pmRNSHolding(s) in Company
9th Sep 20192:11 pmRNSDirector/PDMR Shareholding
2nd Sep 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSHalf-year Report
6th Aug 20194:40 pmRNSNotice of Results
31st Jul 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSDirector/PDMR Shareholding
14th May 20192:34 pmRNSResult of AGM
7th May 20191:23 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
25th Apr 20197:00 amRNSBlock listing Interim Review
16th Apr 20197:00 amRNSNotice of AGM
12th Apr 201910:17 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSNotice of Results
31st Dec 20187:00 amRNSTotal Voting Rights
17th Dec 20185:36 pmRNSDirectorate Change
13th Dec 20189:30 amRNSDirector/PDMR Shareholding
12th Dec 20187:00 amRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
6th Nov 20188:27 amRNSDirector/PDMR Shareholding
25th Oct 20187:00 amRNSBlock listing Interim Review
1st Oct 20187:00 amRNSNew Senior Independent Director
30th Aug 20187:00 amRNSHalf-year Report
6th Aug 20183:37 pmRNSNotice of H1 Results
10th Jul 20187:00 amRNSHolding(s) in Company
6th Jul 20187:00 amRNSHolding(s) in Company
5th Jul 20187:00 amRNSHolding(s) in Company
21st May 20185:16 pmRNSPDMR and Total Voting Rights
16th May 20183:58 pmRNSResults of AGM
1st May 20187:00 amRNSDirector/PDMR Shareholding
24th Apr 20187:00 amRNSChesnara plc - Application for Block Listing
17th Apr 20187:00 amRNSNotice of AGM and Annual Report & Accounts
29th Mar 20187:00 amRNSFinal Results
15th Mar 20187:00 amRNSNotice of Results
14th Mar 201810:47 amRNSHolding(s) in Company
8th Mar 201810:13 amRNSHolding(s) in Company
5th Mar 20182:29 pmRNSExternal Chair appointment for Mike Evans
12th Jan 20183:05 pmRNSHolding(s) in Company
6th Dec 201710:21 amRNSTotal Voting Rights
4th Dec 20172:39 pmRNSHolding(s) in Company
24th Nov 201710:08 amRNSDirector/PDMR Shareholding
24th Nov 20177:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.